Clinical TrialID 966
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
NCT03407716
Cancer Survivor|Stage I Breast Cancer AJCC v7|Stage I Colon Cancer AJCC v6 and v7|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage II Breast Cancer AJCC v6 and v7|Stage II Colon Cancer AJCC v7|Stage II
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 966
- Evidence Id
- 966
- Core Evidence Id
- 966
- Source Clinical Trial Id
- 947
- Herb2 Clinical Trial Id
- HBCT000947
- Nct Id
- NCT03407716
- Title
- Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
- Status
- Completed
- Phase
- Early_Phase 1
- Study Result
- No
- Study Condition
- Cancer Survivor|Stage I Breast Cancer AJCC v7|Stage I Colon Cancer AJCC v6 and v7|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage II Breast Cancer AJCC v6 and v7|Stage II Colon Cancer AJCC v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIA Colon Cancer AJCC v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage IIB Colon Cancer AJCC v7|Stage IIC Colon Cancer AJCC v7|Stage III Breast Cancer AJCC v7|Stage III Colon Cancer AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colon Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colon Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colon Cancer AJCC v7
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
- Intervention
- DRUG: American Ginseng|OTHER: Laboratory Biomarker Analysis|OTHER: Placebo|OTHER: Questionnaire Administration
- Intervention Allocation
- Randomized
- Intervention Model
- Crossover
- Intervention Mask
- Double
- Intervention Purpose
- Supportive_Care
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 2
- Outcome Measure
- Change in general subscale of the Multidimensional Fatigue Symptom Inventory- Short Form (MFSI-SF), Will be evaluated by taking the change from baseline in the general subscale of the MFSI-SF and comparing the two arms by a two-sample, two-sided t-test. If there is evidence of non-normality (via Shapiro-Wilk testing), a non-parametric procedure such as Wilcoxon rank sum will be used. Graphical procedures will include stream plots of individual patient scores and plots of average values over time for each treatment group. Supplemental tests on endpoints (paired t-test for continuous/ordinal data; McNemar?s test for binary data; and Bowker?s test for categorical data) will be utilized to deter, Baseline up to day 56
- Sponsor Collaborator
- Mayo Clinic|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States
- Other Id
- MC16C2|NCI-2017-02494|MC16C2
- Start Date
- 2019-03-01
- Primary Completion Date
- 2020-05-13
- Completion Date
- 2021-02-22
- First Posted
- 2018-01-23
- Results First Posted
- Last Update Posted
- 2023-01-05
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03407716
- Title Cn
- Title En
- Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
- Bilingual Status
- semi_complete